Professional Marketing briefs

Enzo Life Sciences, a division of Enzo Biochem Inc., has named Kara Cannon head of global marketing. She was previously at the Pall Corporation, holding executive positions in diagnostics, biotechnology and biosciences. 

Healthcare market research firm Manhattan Research has released data from its Digital MedTech Physician study, which focuses on the needs of device and medtech marketers. More than 800 practicing US physicians were surveyed on the digital channels they use to learn about medical devices and how they connect with device companies. 

Concentric Pharma Advertising has launched a campaign for Oceana Therapeutics' Solesta, a device indicated to treat adult fecal incontinence. Concentric has also created the website SolestaInfo.com, which provides more information for HCPs and consumers.

ImpactRx, a company known for measuring the impact of promotion on physician prescribing behavior, has acquired TargetRx, Inc., an insight provider into the drivers of HCP behavior on pharma companies. The new company will be known as ImpactRx and led by current ImpactRx president and CEO, Gregory Ellis.

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.